Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
Gerards Goh Helen Kavnoudias Jee Fu Huang Andrew Holden Markd Goodwin Department Of Internal Medicine
Source: prnewswire.com